Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 15, 2003. The report details specific corporate actions regarding share repurchases and updates on director interests in company shares.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on transactional data related to share movements:
- Share Repurchase Price: 1,235.69 pence per share.
- ADS Purchase Price (Dr. Shapiro): $39.5227 per ADS.
- Retirement Fund Average Price: $39.76 per Ordinary Share ADR.
Material Changes
The following material changes occurred during the reporting period:
- Share Cancellation: The company purchased 500,000 Ordinary 25 pence shares for cancellation on August 14, 2003, utilizing authority granted at the May 19, 2003 Annual General Meeting.
- Director Interest (Dr. L. Shapiro): 368 American Depository Shares (ADS) were purchased for Dr. Shapiro on August 13, 2003, under the Scientific Advisory Board Share Allocation Plan.
- Retirement Fund Movement: The GlaxoSmithKline US Retirement Savings Plan saw a decrease in holdings from 19,070,791 to 18,932,799 Ordinary Share ADRs due to fund movements on August 14, 2003. This affects the potential interest of Director Dr. J.P. Garnier.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risk factors, contingencies, or unusual items beyond the routine share transactions and director interest disclosures noted above.
Investor Verification Checklist
- Verify the total number of shares repurchased for cancellation against the company's authorized buyback limit.
- Confirm the impact of the 500,000 share cancellation on the total outstanding share count.
- Review the full terms of the Scientific Advisory Board Share Allocation Plan regarding Dr. Shapiro's holdings.
- Assess the significance of the 137,992 ADR reduction in the US Retirement Savings Plan relative to total fund assets.